HEPATITIS-B VACCINE RESPONSIVENESS IN CONNECTICUT PUBLIC SAFETY PERSONNEL

被引:154
作者
ROOME, AJ
WALSH, SJ
CARTTER, ML
HADLER, JL
机构
[1] CONNECTICUT DEPT HLTH & ADDICT SERV,EPIDEMIOL SECT,150 WASHINGTON ST,HARTFORD,CT 06106
[2] UNIV CONNECTICUT,CTR HLTH,DEPT COMMUNITY MED,FARMINGTON,CT 06032
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1993年 / 270卷 / 24期
关键词
D O I
10.1001/jama.270.24.2931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To determine the level and determinants of vaccine response in recently inoculated public safety personnel. Design.-Prevalence survey. Participants.-Public safety personnel who had completed vaccination 1 to 6 months prior to testing and had no serological evidence of previous exposure to hepatitis B virus. Main Outcome Measure.-An inadequate level of antibody to hepatitis B surface antigen was defined as less than 10 mIU/mL. Results.-All subjects in the study had been vaccinated using Recombivax HB, a recombinant hepatitis B vaccine. Of 528 individuals, 11.9% were found to have no or inadequate levels of antibody. The frequency of inadequate level of antibody increased significantly relative to age, from 2.8% among those younger than 30 years to 42.1% among those older than 60 years (P<.0001). Smoking (odds ratio [OR], 3.6; 95% confidence interval [CI], 2.0 to 6.4), extreme obesity (OR, 13.3; 95% CI, 3.8 to 49.1), and increasing time interval since completing the vaccine series (P<.01) were also associated with inadequate levels of antibody. These findings were confirmed by multivariate analysis using logistic regression. Conclusions.-Routine immunization of public safety personnel should include selective use of postvaccine testing. Postvaccination testing optimally should be performed in the 30- to 90-day interval after the last vaccine dose. New vaccination strategies are needed to improve response rates in persons with predictably poor response to hepatitis B vaccine.
引用
收藏
页码:2931 / 2934
页数:4
相关论文
共 15 条
[1]   THE CHANGING EPIDEMIOLOGY OF HEPATITIS-B IN THE UNITED-STATES - NEED FOR ALTERNATIVE VACCINATION STRATEGIES [J].
ALTER, MJ ;
HADLER, SC ;
MARGOLIS, HS ;
ALEXANDER, WJ ;
HU, PY ;
JUDSON, FN ;
MARES, A ;
MILLER, JK ;
MOYER, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (09) :1218-1222
[2]   SUMMARY OF SAFETY AND EFFICACY DATA ON A YEAST-DERIVED HEPATITIS-B VACCINE [J].
ANDRE, FE .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3A) :S14-S20
[3]   FEASIBILITY OF CONTROLLING OR ERADICATING THE HEPATITIS-B VIRUS [J].
BLUMBERG, BS .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3A) :S2-S4
[4]   LONG-TERM IMMUNOGENICITY AND EFFICACY OF HEPATITIS-B VACCINE IN HOMOSEXUAL MEN [J].
HADLER, SC ;
FRANCIS, DP ;
MAYNARD, JE ;
THOMPSON, SE ;
JUDSON, FN ;
ECHENBERG, DF ;
OSTROW, DG ;
OMALLEY, PM ;
PENLEY, KA ;
ALTMAN, NL ;
BRAFF, E ;
SHIPMAN, GF ;
COLEMAN, PJ ;
MANDEL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :209-214
[5]   DURATION OF IMMUNITY AFTER HEPATITIS-B VACCINATION - EFFICACY OF LOW-DOSE BOOSTER VACCINE [J].
HOROWITZ, MM ;
ERSHLER, WB ;
MCKINNEY, WP ;
BATTIOLA, RJ .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :185-189
[6]   IMMUNOGENICITY OF RECOMBINANT HEPATITIS-B VACCINE IN DIALYSIS PATIENTS [J].
JILG, W ;
SCHMIDT, M ;
WEINEL, B ;
KUTTLER, T ;
BRASS, H ;
BOMMER, J ;
MULLER, R ;
SCHULTE, B ;
SCHWARZBECK, A ;
DEINHARDT, F .
JOURNAL OF HEPATOLOGY, 1986, 3 (02) :190-195
[7]   EFFECT OF CIGARETTE-SMOKING ON SUSCEPTIBILITY TO EPIDEMIC INFLUENZA AND ON SEROLOGICAL RESPONSES TO LIVE ATTENUATED AND KILLED SUBUNIT INFLUENZA VACCINES [J].
MACKENZIE, JS ;
MACKENZIE, IH ;
HOLT, PG .
JOURNAL OF HYGIENE, 1976, 77 (03) :409-417
[8]   HEPATITIS-B - EVOLVING EPIDEMIOLOGY AND IMPLICATIONS FOR CONTROL [J].
MARGOLIS, HS ;
ALTER, MJ ;
HADLER, SC .
SEMINARS IN LIVER DISEASE, 1991, 11 (02) :84-92
[9]   EFFECT OF ANATOMIC INJECTION SITE, AGE AND SMOKING ON THE IMMUNE-RESPONSE TO HEPATITIS-B VACCINATION [J].
SHAW, FE ;
GUESS, HA ;
ROETS, JM ;
MOHR, FE ;
COLEMAN, PJ ;
MANDEL, EJ ;
ROEHM, RR ;
TALLEY, WS ;
HADLER, SC .
VACCINE, 1989, 7 (05) :425-430
[10]   YEAST-RECOMBINANT HEPATITIS-B VACCINE - EFFICACY WITH HEPATITIS-B IMMUNE GLOBULIN IN PREVENTION OF PERINATAL HEPATITIS-B VIRUS TRANSMISSION [J].
STEVENS, CE ;
TAYLOR, PE ;
TONG, MJ ;
TOY, PT ;
VYAS, GN ;
NAIR, PV ;
WEISSMAN, JY ;
KRUGMAN, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (19) :2612-2616